Artificial Intelligence in Diagnostics Market Analysis

  • Report ID: 6488
  • Published Date: Sep 30, 2024
  • Report Format: PDF, PPT

Artificial Intelligence in Diagnostics Market Analysis

Component (Software, Services, Hardware)

The software segment is anticipated to dominate the AI in diagnostics market, with a share of 58.6% in the forecast period. This is due to the rising demand for diagnostic software integrated with AI to strengthen the diagnostic workflow for the early detection and diagnosis of diseases. The key functions accompanying AI-driven software applications in medical imaging include lesion detection, radiology workflow management, and predictive analytics, which are highly critical in a modern clinical setting.

Software solutions are provided to streamline diagnostic processes and minimize human errors to enable informed decisions by clinicians. For example, Roche entered into a partnership with PathAI in February 2024 to co-develop AI-based pathology software that could be integrated with streamlined workflow processes for pathologists. This further illustrates how much diagnostics AI-based collaborations can rely on software, as it greatly contributes to improving clinical outcomes by bringing in the prospects of quicker and more accurate detection of diseases.

End use (Hospitals & clinics, Diagnostic laboratories, Imaging centers, Other End users)

The hospitals and clinics segment is likely to continue leading the artificial intelligence in diagnostics market and account for a 45.2% share throughout the forecast period. This growth is due to increased patient numbers and the higher acceptance of AI diagnostics in clinical settings, where the need for efficient and clear diagnostic tools is unprecedented. Siemens Healthineers announced a partnership with Ohio State Wexner Medical Center in January 2022 to provide advanced imaging technologies along with AI-powered diagnostic solutions. It further positioned hospitals as the key driver for AI adoption. The collaboration illustrates just how crucial a role this technology plays in major healthcare institutions in elevating diagnostic capabilities.

Our in-depth analysis of the AI in diagnostics market includes the following segments:

Component

  • Hardware
  • Services
  • Software

Application

  • Radiology
  • Oncology
  • Cardiology
  • Neurology
  • Pathology
  • Infectious diseases
  • Other applications

End use

  • Hospitals & clinics
  • Diagnostic laboratories
  • Imaging centers
  • Other end users
Get more information on this report: Request Free Sample PDF


Author Credits:  Radhika Pawar


  • Report ID: 6488
  • Published Date: Sep 30, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The artificial intelligence in diagnostics market size is USD 1.3 billion in 2024.

The global artificial intelligence in diagnostics market size was valued at US 1.3 billion in 2024 and is anticipated to surpass USD 19.9 billion by the end of 2037, rising at a CAGR of 23.0% over the forecast period, i.e., 2025-2037.

Key players in the market are IBM Corporation, Imagen Technologies, including Aidoc, AliveCor Inc., Digital Diagnostics, Inc., Enlitic, NVIDIA Corporation, PathAI, RADLogics, and Riverain Technologies.

The software segment is expected to hold a dominating share during the forecast period.

North America is anticipated to dominate the industry with a share of 41.5% during the forecast period.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample